VRC-FLUMOS0122-00-VP (SteMos1) Quadrivalent Influenza HA Stem Vaccine

Quadrivalent influenza HA stem vaccine · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VRC-FLUMOS0122-00-VP (SteMos1) Quadrivalent Influenza HA Stem Vaccine, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults [Phase 1]

See pricing